Ceruloplasmin Test in UAE | 140 AED | DHA-Approved Diagnostic Lab

Executive Summary & Core Metrics

Trusted Diagnostic Excellence — Direct Billing Verification

99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Nephelometry.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed General Practitioner.
Insurance Made Easy: Direct Billing Verification via WhatsApp +971 54 548 8731 — share your Emirates ID and policy card.

Test Overview & Methodology

The Ceruloplasmin Test quantifies a copper-carrying glycoprotein essential for iron mobilization and systemic antioxidant defence. Clinically, it is requested to evaluate Wilson disease, hepatocellular dysfunction, and acquired copper deficiency states. Measurement is performed by high-sensitivity nephelometry calibrated against the ERM-DA470k international reference material, ensuring traceable and reproducible results across serial assessments.

Feature	DNA Labs UAE Service (DHA-Approved)	Standard Lab Alternative
Precision	99.9% Sensitivity — ISO 9001:2015 Nephelometry	Conventional immunoturbidimetry; higher inter-assay CV
Methodology	High-sensitivity Nephelometry (DHA/MOHAP Standard)	Basic turbidimetry; not referenced to ERM-DA470k
Reporting Speed	Same day (if drawn before 9 AM Sun–Thu or by 4 PM Mon–Sat)	Typically 24–48 hours

Physician Insight & Safety Protocols

Ceruloplasmin values must be interpreted alongside serum copper, 24-hour urinary copper excretion, and liver function tests. A low concentration strongly suggests Wilson disease, yet acute inflammation, pregnancy, or oestrogen therapy can elevate the protein. Always correlate clinically before altering patient management.

— Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132)

Important Advisory — Medication & Preparation

Do not discontinue prescribed medications or supplements without consulting your physician. Overnight fasting is preferred; avoid high-copper foods such as shellfish and organ meats for 24 hours prior to collection if possible, but never stop any prescribed therapy on your own.

Exclusion Criteria & Emergency Red Flags

Patients with known acute liver failure or decompensated cirrhosis — this test alone is insufficient; urgent specialist consultation is required.
Do not schedule home collection if you are experiencing severe abdominal pain, jaundice with confusion, or haematemesis; proceed to the nearest emergency department immediately.
Minors under 18 years require a guardian's written consent; the guardian must be present during the collection procedure.
Results should not be used in isolation to diagnose Wilson disease; confirmatory genetic testing (ATP7B) and liver biopsy may be indicated.

Patient FAQ & Clinical Guidance

1. What does a ceruloplasmin test detect and why is it ordered?

The test measures the primary copper-transport protein in blood. It is ordered to screen for Wilson disease, investigate unexplained liver dysfunction, and assess copper deficiency states such as Menkes disease or malabsorption syndromes.

2. How should I prepare for the ceruloplasmin test in the UAE?

Overnight fasting is recommended. Refrain from consuming shellfish, liver, and copper-containing supplements for 24 hours prior to collection to avoid transient elevation of copper levels.

3. What do low ceruloplasmin levels indicate and what are the next steps?

Persistently low ceruloplasmin is a hallmark of Wilson disease and warrants immediate 24-hour urinary copper quantification, slit-lamp eye examination for Kayser–Fleischer rings, and ATP7B gene sequencing.

4. Can I take the test while on copper-containing supplements?

Yes, but inform your physician about all supplements. Certain formulations may transiently elevate ceruloplasmin levels. Your doctor will advise the optimal timing relative to your dosing schedule.

UAE Regulatory & Data Privacy Adherence

Trust, Safety & Compliance

Data Privacy: All patient information is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
Health Information Governance: Clinical data handling adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Medical Liability: Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Certification: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Laboratory operations are under the regulatory purview of the Dubai Health Authority (DHA).

Clinical & Logistical Metadata

Test Name	Ceruloplasmin Test (Serum / Plasma)
Price (AED)	140 AED
Turnaround Time	Same day (if drawn before 9 AM Sun–Thu or by 4 PM Mon–Sat)
Sample Type / Matrix	Serum or Plasma — standard venipuncture; VIP Mobile Phlebotomy available daily 8 AM – 11 PM
Methodology Used	High-sensitivity Nephelometry (ISO 9001:2015, calibrated to ERM-DA470k)
ICD-10-CM Code	E83.01, K76.0, K74.69
LOINC Code	2064-4
DHA Facility License & Address	License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE